• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TNF-α 与 ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗后的心肌灌注和功能。

TNF-α, myocardial perfusion and function in patients with ST-segment elevation myocardial infarction and primary percutaneous coronary intervention.

机构信息

Division of Cardiology, Pulmonary Diseases and Vascular Medicine, Department of Medicine, University Hospital Aachen, 52074 Aachen, Germany.

出版信息

Clin Res Cardiol. 2012 Oct;101(10):815-27. doi: 10.1007/s00392-012-0465-x. Epub 2012 May 6.

DOI:10.1007/s00392-012-0465-x
PMID:22562290
Abstract

AIMS

To characterize the time course of tumor necrosis factor-α (TNF-α) serum levels along with myocardial perfusion and contractile function in patients with ST-segment elevation myocardial infarction (STEMI) and successful primary percutaneous coronary intervention (PCI).

METHODS

Serum levels of TNF-α, interleukin 6 (IL-6), and C-reactive protein (CRP) were measured in 42 patients with STEMI before, one and 6 days after successful PCI. Myocardial perfusion was assessed by contrast-enhanced echocardiography (ceEcho), contractile function by unenhanced two-dimensional (2DE) and real-time three-dimensional echocardiography. In a subset of 18 patients, infarct size was quantified by late gadolinium enhancement cardiovascular magnetic resonance imaging (LGE-CMR) on day six.

RESULTS

TNF-α serum levels were in the upper normal range within the first 12 h from symptom onset and increased continuously until day six, while IL-6 and CRP increased subsequently with a peak on day one after STEMI. Serum TNF-α on day one after PCI correlated with perfusion defects, wall motion abnormalities, and infarct size (ceEcho: r = 0.52, p = 0.005; 2DE: r = 0.56, p = 0.002; LGE-CMR: r = 0.83-0.86; p < 0.0001). Using multiple regression linear analysis, infarct size on day six was predicted by serum TNF-α 1 day after PCI (p = 0.006, adjusted R (2) 0.638).

CONCLUSION

Our data reflect the clinical significance of early TNF-α elevation in patients with STEMI and primary PCI (Controlled Clinical Trials number, NCT00529607).

摘要

目的

描述 ST 段抬高型心肌梗死(STEMI)患者成功接受经皮冠状动脉介入治疗(PCI)后,肿瘤坏死因子-α(TNF-α)血清水平与心肌灌注和收缩功能的时间进程。

方法

42 例 STEMI 患者于 PCI 成功前、后第 1 天及第 6 天,检测 TNF-α、白细胞介素 6(IL-6)和 C 反应蛋白(CRP)的血清水平。采用对比增强超声心动图(ceEcho)评估心肌灌注,二维(2DE)和实时三维超声心动图评估收缩功能。在 18 例患者亚组中,于第 6 天采用钆延迟增强心血管磁共振成像(LGE-CMR)定量梗死面积。

结果

STEMI 发病后 12 小时内,TNF-α 血清水平处于正常上限范围内,并持续升高至第 6 天,而 IL-6 和 CRP 则随后升高,在 STEMI 后第 1 天达到峰值。PCI 后第 1 天的血清 TNF-α与灌注缺损、室壁运动异常和梗死面积相关(ceEcho:r=0.52,p=0.005;2DE:r=0.56,p=0.002;LGE-CMR:r=0.83-0.86;p<0.0001)。采用多元线性回归分析,第 6 天的梗死面积由 PCI 后第 1 天的血清 TNF-α预测(p=0.006,调整后的 R2为 0.638)。

结论

我们的数据反映了 TNF-α 在 STEMI 患者接受 PCI 后的早期升高具有临床意义(临床试验注册号:NCT00529607)。

相似文献

1
TNF-α, myocardial perfusion and function in patients with ST-segment elevation myocardial infarction and primary percutaneous coronary intervention.TNF-α 与 ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗后的心肌灌注和功能。
Clin Res Cardiol. 2012 Oct;101(10):815-27. doi: 10.1007/s00392-012-0465-x. Epub 2012 May 6.
2
Cardiac magnetic resonance derived late microvascular obstruction assessment post ST-segment elevation myocardial infarction is the best predictor of left ventricular function: a comparison of angiographic and cardiac magnetic resonance derived measurements.心脏磁共振衍生的 ST 段抬高型心肌梗死梗死后晚期微血管阻塞评估是左心室功能的最佳预测指标:血管造影和心脏磁共振衍生测量的比较。
Int J Cardiovasc Imaging. 2012 Dec;28(8):1971-81. doi: 10.1007/s10554-012-0021-9. Epub 2012 Feb 5.
3
Time-dependency, predictors and clinical impact of infarct transmurality assessed by magnetic resonance imaging in patients with ST-elevation myocardial infarction reperfused by primary coronary percutaneous intervention.经皮冠状动脉介入治疗再通的 ST 段抬高型心肌梗死患者磁共振成像评估的梗死透壁程度的时间依赖性、预测因素和临床影响。
Clin Res Cardiol. 2012 Mar;101(3):191-200. doi: 10.1007/s00392-011-0380-6. Epub 2011 Nov 10.
4
Randomized comparison of pre-hospital-initiated facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention in acute myocardial infarction very early after symptom onset: the LIPSIA-STEMI trial (Leipzig immediate prehospital facilitated angioplasty in ST-segment myocardial infarction).症状发作后极早期行院前启动的辅助经皮冠状动脉介入治疗与直接经皮冠状动脉介入治疗治疗急性心肌梗死的随机比较:LIPSIA-STEMI 试验(莱比锡即刻院前辅助 ST 段抬高型心肌梗死血管成形术)
JACC Cardiovasc Interv. 2011 Jun;4(6):605-14. doi: 10.1016/j.jcin.2011.01.013.
5
Association of TIMI myocardial perfusion grade and ST-segment resolution with cardiovascular magnetic resonance measures of microvascular obstruction and infarct size following ST-segment elevation myocardial infarction.ST段抬高型心肌梗死后,TIMI心肌灌注分级及ST段回落与心血管磁共振微血管阻塞和梗死面积测量指标的相关性
J Thromb Thrombolysis. 2009 Feb;27(2):123-9. doi: 10.1007/s11239-008-0197-y. Epub 2008 Feb 2.
6
Microvascular perfusion in infarcted and remote myocardium after successful primary PCI: angiographic and CMR findings.成功的直接经皮冠状动脉介入治疗后梗死和远隔心肌的微血管灌注:血管造影和 CMR 结果。
Eur Radiol. 2019 Feb;29(2):941-950. doi: 10.1007/s00330-018-5588-7. Epub 2018 Jul 6.
7
Pentraxin 3 in primary percutaneous coronary intervention for ST elevation myocardial infarction is associated with early irreversible myocardial damage : Kinetic profile, relationship to interleukin 6 and infarct size.Pentraxin 3 在 ST 段抬高型心肌梗死的直接经皮冠状动脉介入治疗中的作用与早期不可逆转的心肌损伤有关:动力学特征、与白细胞介素 6 的关系和梗死面积。
Eur Heart J Acute Cardiovasc Care. 2020 Jun;9(4):302-312. doi: 10.1177/2048872620923641. Epub 2020 May 14.
8
Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".急性ST段抬高型心肌梗死(STEMI)后早期对比增强心脏磁共振成像(CMR)对区域STEMI网络的预后影响:“埃森心肌梗死联盟”的研究结果
Herz. 2008 Mar;33(2):136-42. doi: 10.1007/s00059-008-3102-8.
9
Intracoronary ECG during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction predicts microvascular obstruction and infarct size.经皮冠状动脉介入治疗 ST 段抬高型心肌梗死时的冠状动脉内心电图预测微血管阻塞和梗死面积。
Int J Cardiol. 2013 Apr 30;165(1):61-6. doi: 10.1016/j.ijcard.2011.07.078. Epub 2011 Aug 28.
10
Impact of infarct location and size on clinical outcome after ST-elevation myocardial infarction treated by primary percutaneous coronary intervention.梗死部位和大小对接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者临床结局的影响。
Int J Cardiol. 2020 Feb 15;301:14-20. doi: 10.1016/j.ijcard.2019.11.123. Epub 2019 Nov 17.

引用本文的文献

1
Anti-inflammatory effects of proprotein convertase subtilisin/kexin 9 inhibitor therapy in the early phase of acute myocardial infarction.前蛋白转化酶枯草溶菌素/克新9抑制剂疗法在急性心肌梗死早期的抗炎作用
Heart Vessels. 2025 Apr;40(4):312-319. doi: 10.1007/s00380-024-02473-8. Epub 2024 Oct 5.
2
Influence of metabolic syndrome on plaque features and clinical outcomes in patients with acute coronary syndrome.代谢综合征对急性冠状动脉综合征患者斑块特征及临床结局的影响。
Clin Res Cardiol. 2025 Jun;114(6):760-771. doi: 10.1007/s00392-024-02540-0. Epub 2024 Sep 16.
3
The roles of Th cells in myocardial infarction.

本文引用的文献

1
Inhibition of neointimal hyperplasia with a novel zotarolimus coated balloon catheter.新型佐他莫司涂层球囊导管抑制内膜增生。
Clin Res Cardiol. 2012 Jun;101(6):469-76. doi: 10.1007/s00392-012-0415-7.
2
Efficacy and safety of a high loading dose of clopidogrel administered prehospitally to improve primary percutaneous coronary intervention in acute myocardial infarction: the randomized CIPAMI trial.院前给予高负荷剂量氯吡格雷对改善急性心肌梗死患者直接经皮冠状动脉介入治疗的疗效和安全性:随机 CIPAMI 试验。
Clin Res Cardiol. 2012 Apr;101(4):305-12. doi: 10.1007/s00392-011-0393-1. Epub 2011 Dec 21.
3
PCI ad hoc or PCI at an interval: a risk calculation.
辅助性T细胞在心肌梗死中的作用。
Cell Death Discov. 2024 Jun 15;10(1):287. doi: 10.1038/s41420-024-02064-6.
4
Expression and clinical significance of NRLP1 in patients with ST-segment elevation myocardial infarction combined with malignant ventricular arrhythmia.NRLP1在ST段抬高型心肌梗死合并恶性室性心律失常患者中的表达及临床意义
Pak J Med Sci. 2023 Jul-Aug;39(4):972-977. doi: 10.12669/pjms.39.4.7324.
5
The abnormal level and prognostic potency of multiple inflammatory cytokines in PCI-treated STEMI patients.经皮冠状动脉介入治疗(PCI)治疗的 ST 段抬高型心肌梗死(STEMI)患者多种炎症细胞因子的异常水平及其预后能力。
J Clin Lab Anal. 2022 Nov;36(11):e24730. doi: 10.1002/jcla.24730. Epub 2022 Oct 17.
6
Fibroblast activation protein imaging in reperfused ST-elevation myocardial infarction: comparison with cardiac magnetic resonance imaging.再灌注治疗的 ST 段抬高型心肌梗死中的成纤维细胞激活蛋白成像:与心脏磁共振成像的比较。
Eur J Nucl Med Mol Imaging. 2022 Jul;49(8):2786-2797. doi: 10.1007/s00259-021-05674-9. Epub 2022 Jan 5.
7
Potential Effects of CXCL9 and CCL20 on Cardiac Fibrosis in Patients with Myocardial Infarction and Isoproterenol-Treated Rats.CXCL9和CCL20对心肌梗死患者及异丙肾上腺素处理大鼠心脏纤维化的潜在影响
J Clin Med. 2019 May 11;8(5):659. doi: 10.3390/jcm8050659.
8
Dynamic Profile of CD4 T-Cell-Associated Cytokines/Chemokines following Murine Myocardial Infarction/Reperfusion.心肌梗死/再灌注后小鼠 CD4+T 细胞相关细胞因子/趋化因子的动态谱。
Mediators Inflamm. 2019 Mar 18;2019:9483647. doi: 10.1155/2019/9483647. eCollection 2019.
9
Unmet Needs in the Pathogenesis and Treatment of Cardiovascular Comorbidities in Chronic Inflammatory Diseases.慢性炎症性疾病中心血管合并症的发病机制和治疗中的未满足需求。
Clin Rev Allergy Immunol. 2018 Dec;55(3):254-270. doi: 10.1007/s12016-017-8624-5.
10
Apoptosis in ischemic heart disease.缺血性心脏病中的细胞凋亡
J Transl Med. 2017 May 1;15(1):87. doi: 10.1186/s12967-017-1191-y.
Clin Res Cardiol. 2012 Feb;101(2):155-7. doi: 10.1007/s00392-011-0399-8. Epub 2011 Dec 16.
4
Concurrent drug eluting/bare metal stent implantation during percutaneous coronary intervention in target vessel: outcomes and 1-year follow-up.经皮冠状动脉介入治疗中同时植入药物洗脱/裸金属支架:结果和 1 年随访。
Clin Res Cardiol. 2012 Apr;101(4):281-8. doi: 10.1007/s00392-011-0390-4. Epub 2011 Dec 9.
5
Real-world experience of drug-eluting stents in saphenous vein grafts compared to native coronary arteries: results from the prospective multicenter German DES.DE registry.比较药物洗脱支架在静脉桥血管与原生冠状动脉中的真实世界应用经验:来自前瞻性多中心德国 DES.DE 注册研究的结果。
Clin Res Cardiol. 2012 Mar;101(3):201-8. doi: 10.1007/s00392-011-0381-5. Epub 2011 Nov 13.
6
Time-dependency, predictors and clinical impact of infarct transmurality assessed by magnetic resonance imaging in patients with ST-elevation myocardial infarction reperfused by primary coronary percutaneous intervention.经皮冠状动脉介入治疗再通的 ST 段抬高型心肌梗死患者磁共振成像评估的梗死透壁程度的时间依赖性、预测因素和临床影响。
Clin Res Cardiol. 2012 Mar;101(3):191-200. doi: 10.1007/s00392-011-0380-6. Epub 2011 Nov 10.
7
First clinical evaluation of a novel capacitive ECG system in patients with acute myocardial infarction.新型电容式心电图系统在急性心肌梗死患者中的首次临床评估。
Clin Res Cardiol. 2012 Mar;101(3):165-74. doi: 10.1007/s00392-011-0377-1. Epub 2011 Nov 8.
8
Clinical feasibility study for detection of myocardial oedema by a cine SSFP sequence in comparison to a conventional T2-weighted sequence.心肌水肿的电影 SSFP 序列与常规 T2 加权序列检测的临床可行性研究。
Clin Res Cardiol. 2012 Feb;101(2):125-31. doi: 10.1007/s00392-011-0373-5. Epub 2011 Oct 30.
9
Platelet inhibition and GP IIb/IIIa receptor occupancy by intracoronary versus intravenous bolus administration of abciximab in patients with ST-elevation myocardial infarction.经皮冠状动脉介入治疗中与静脉推注相比,血小板抑制和糖蛋白 IIb/IIIa 受体占有率与冠状动脉内应用阿昔单抗在 ST 段抬高型心肌梗死患者中的关系。
Clin Res Cardiol. 2012 Feb;101(2):117-24. doi: 10.1007/s00392-011-0372-6. Epub 2011 Oct 21.
10
In-hospital prognostic value of hemoglobin levels on admission in patients with acute ST segment elevation myocardial infarction undergoing primary angioplasty.急性 ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗时入院时血红蛋白水平的院内预后价值。
Clin Res Cardiol. 2012 Jan;101(1):37-44. doi: 10.1007/s00392-011-0361-9. Epub 2011 Sep 20.